Not all people with CLL require therapy. Even with all modern improvements, the iwCLL nevertheless endorses watchful observation for patients with asymptomatic disease.86 This suggestion relies on at least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). yang terbaru setiap harinya. Sehingga memudahkan https://kirkp530ktb8.wikiconverse.com/user